Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bisoprolol in idiopathic pulmonary arterial hypertension
NL-OMON34177Phase 2Active, not recruiting
- Sponsor
- Vrije University Medical Center
- Start
- Feb 2011
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of bisoprolol in Plexogenic Pulmonary Arteriopathy (2 arms), sponsored by Vrije University Medical Center. Primary endpoint: Right ventricular ejection fraction. Started Feb 2011; status: active, not recruiting.
02
Drugs
bisoprolol
03
Conditions
Plexogenic Pulmonary Arteriopathy
Beyond the preview
Go deeper on NL-OMON34177.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON34177.